Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01OWJ
|
|||
| Former ID |
DIB009883
|
|||
| Drug Name |
TG-1024
|
|||
| Synonyms |
Ad-IL-2, Transgene; Adenoviral-IL-2, Transgene
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Discontinued in Phase 1 | [1] | |
| Company |
Transgene SA; Transgene
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009282) | |||
| REF 2 | Melanoma and Immunotherapy. Hematology/Oncology Clinics of North America Volume 23, Issue 3, June 2009, Pages 547-564. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.